Partner with JAX-NYSCF
Read Flipbook
ISSCR 2026
We are dedicated to providing clinically predictive preclinical models, services, and research assays to advance your oncology research and biologic development. Together, let’s bridge the translational gap and accelerate your scientific breakthroughs.
-
-
Powering Discovery with JAX iPSC Models
Read Flipbook
-
Loading, please wait
Error - something went wrong!
Register to Attend our Innovation Showcase
Thank you! We will be in touch soon.
-
Engineered vs. Patient-Derived iPSCs: Strengths, Limitations, and Applications
Induced pluripotent stem cells (iPSCs) have become a cornerstone of modern biomedical research, offering unprecedented opportunities to model human development, investigate disease mechanisms, and...
Learn More
-
Why Clonal iPSC Lines Are Essential: Building a Foundation for Reliable and Reproducible Research
Induced pluripotent stem cells (iPSCs) have become indispensable tools in modern biomedical research and are transforming how we model human disease, discover drugs, and explore regenerative...
Learn More
-
Defining a Reference iPSC Line: Criteria, Context, and the Case of KOLF2.1J
In the field of stem cell research, the quest to define a “reference” induced pluripotent stem cell (iPSC) line is ongoing and nuanced. As we deepen our understanding of human biology, one thing...
Learn More
-
From iPSCs to Microglia in Record Time: A Xeno-Free, Tet-Inducible Differentiation Protocol Using KOLF2.1J.
In this webinar, Dr. Oliveira will introduce JAX’s new Tet-inducible neuron and microglia human induced pluripotent stem cell (hiPSCs) lines.
Watch Video
-
Tools with a Mission: Using Disease Models to Find a Treatment for PURA Syndrome
This webinar explores the urgent need for innovative models and highlights JAX’s development of iPSC lines to advance understanding of PURA syndrome and enable drug discovery.
Watch Video
-
MorPhiC: Decoding Human Protein-Coding Gene Function at Scale in iPSC-Derived Multicellular Systems
Learn about the MorPhiC Consortium and its initiative to generate a comprehensive catalog of molecular and cellular phenotypes for null alleles of every human protein-coding gene.
Watch Video
-
JAX Tech Talk Episode 68: Let’s Talk iPSC Disease Models as a Tool in Drug Discovery (Nov. 7, 2023)
During this JAX Tech Talk, Dr. Steven Rodriguez, Lab Head of the Rare & Neurological Diseases Therapeutic Area at Sanofi, discusses how his group uses iPSC models to understand disease biology.
Watch Video
-
JAX Tech Talk Episode 59: Let’s Talk iPSCs and Their Value in Tackling Neurodegenerative Diseases (Sep. 20, 2022)
Dr. Mark Cookson talks about the unique aspects of the collection of human isogenic iPSC lines and how it can benefit the wider scientific community in their shared quest to understand and fight ADRD.
Watch Video
